The proliferation index of the meningioma at initial diagnosis, defined as mitotic index using anti-pHH3 antibody [9] or as Ki67-MIB1 [4, 7, 24], was significantly correlated with the recurrence and also with the recurrence-free survival [8]. Here, MIB1 is linked to meningioma.